We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
-7.43%
1 Year Est. Return
+89.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$88.9M
AUM Growth
-$12M
Cap. Flow
+$2.84M
Cap. Flow %
3.19%
Top 10 Hldgs %
37.68%
Holding
72
New
15
Increased
33
Reduced
13
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 27.75%
2 Consumer Discretionary 18.04%
3 Industrials 13.54%
4 Real Estate 11.34%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
26
Atea Pharmaceuticals
AVIR
$420M
$1.35M 1.52%
452,060
+123,479
+38% +$385K
CLDT
27
Chatham Lodging
CLDT
$586M
$1.33M 1.49%
+186,356
New +$1.54M
ALOT icon
28
AstroNova
ALOT
$227M
$1.18M 1.33%
128,377
+457
+0.4% +$5.08K
NKTX icon
29
Nkarta
NKTX
$172M
$1.1M 1.24%
+598,245
New +$1.23M
ALTO icon
30
Alto Ingredients
ALTO
$340M
$1.07M 1.21%
942,425
+3,328
+0.4% +$5.15K
CLW icon
31
Clearwater Paper
CLW
$376M
$1.04M 1.17%
+40,884
New +$1.14M
FTEK icon
32
Fuel Tech
FTEK
$43.7M
$1.03M 1.16%
981,102
+3,428
+0.4% +$3.4K
INVE icon
33
Identive
INVE
$61.9M
$982K 1.1%
+307,790
New +$1.08M
MED icon
34
Medifast
MED
$141M
$933K 1.05%
+69,200
New +$1.04M
AXR icon
35
AMREP Corp
AXR
$119M
$904K 1.02%
45,081
+156
+0.3% +$4.17K
CRGX
36
DELISTED
CARGO Therapeutics
CRGX
$892K 1%
+219,077
New +$1.47M
ZNTL icon
37
Zentalis Pharmaceuticals
ZNTL
$302M
$888K 1%
+558,418
New +$1.2M
PLRX icon
38
Pliant Therapeutics
PLRX
$65M
$867K 0.98%
+642,193
New +$3.9M
HOFT icon
39
Hooker Furnishings Corp
HOFT
$166M
$859K 0.97%
85,572
-49,527
-37% -$626K
ITOS
40
DELISTED
iTeos Therapeutics
ITOS
$810K 0.91%
135,655
+26,802
+25% +$197K
ANTX icon
41
AN2 Therapeutics
ANTX
$214M
$790K 0.89%
580,853
+2,028
+0.4% +$2.55K
THRD
42
DELISTED
Third Harmonic Bio
THRD
$777K 0.87%
+223,865
New +$1.09M
KYTX icon
43
Kyverna Therapeutics
KYTX
$484M
$765K 0.86%
+396,221
New +$1.17M
SEER icon
44
Seer Inc
SEER
$120M
$727K 0.82%
430,396
+1,492
+0.3% +$3.25K
UEIC icon
45
Universal Electronics
UEIC
$61.3M
$679K 0.76%
110,882
+386
+0.3% +$3.38K
CLYM
46
Climb Bio
CLYM
$804M
$676K 0.76%
+553,816
New +$898K
CVGI icon
47
Commercial Vehicle Group
CVGI
$147M
$650K 0.73%
+565,090
New +$1.09M
FDMT icon
48
4D Molecular Therapeutics
FDMT
$562M
$633K 0.71%
195,853
+51,110
+35% +$241K
RFL icon
49
Rafael Holdings
RFL
$107M
$629K 0.71%
341,103
+1,191
+0.4% +$2.31K
KZR
50
DELISTED
Kezar Life Sciences
KZR
$607K 0.68%
124,427
+433
+0.3% +$2.63K

Similar funds

Peapod Lane Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Peapod Lane Capital held 72 positions worth $88.9M, down 12% from $101M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Peapod Lane Capital deployed $2.84M of net new capital in Q1 2025, opening 15 new positions and adding to 33 existing holdings. Its largest new stake was Pliant Therapeutics: 642,193 shares worth $867K.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Chimerix, Inc., an estimated $1.85M trimmed.

  • Peapod Lane Capital's largest Q1 2025 buy was Pliant Therapeutics: 642,193 shares worth $867K.
  • Peapod Lane Capital added most to Star Holdings Shares of Beneficial Interest in Q1 2025, an estimated $1.36M increase.
  • Peapod Lane Capital's biggest Q1 2025 reduction was Chimerix, Inc., cutting an estimated $1.85M.
  • Peapod Lane Capital fully exited VOXX International Corporation Class A in Q1 2025, selling an estimated $3.63M.
  • Peapod Lane Capital's ten largest holdings make up 38% of its $88.9M portfolio in Q1 2025.
  • Peapod Lane Capital opened 15 new positions and closed 11 in Q1 2025.
  • Peapod Lane Capital's portfolio value fell 12% quarter-over-quarter to $88.9M.

Based on Peapod Lane Capital's 13F filing for Q1 2025, filed 30 Apr 2025.